Market Introduction & Size Analysis:
The global monoclonal antibodies market is projected to reach approximately US$729.4 billion by the end of 2031, up from US$276.9 billion in 2024, representing a robust CAGR of 12.4% from 2024 to 2031. This growth underscores the increasing importance of monoclonal antibodies within the biopharmaceutical sector.
The Monoclonal antibodies (mAbs) market...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian